GLP-1 receptor agonists represent one of the fastest-growing pharmaceutical classes, with millions of Americans now using these medications for type 2 diabetes and chronic weight management
Some patients also have nausea diarrhea vomiting constipation early on
We hypothesize that conformer 1 is required for G protein activation, and that adoption of this receptor conformation is favored under conditions used to form a stable complex that can be imaged (inclusion of dominant negative G protein and nanobody 35, apyrase treatment)
Additionally, some individuals may experience side effects such as nausea or diarrhea
Craving scores were significantly lower in the GLP-1RA group compared to the control group, as evidenced by a significant main effect of group ( 2 (1) = 4.71, p = 0.03, f = 0.58
Gina Roberts-Grey Author Gina Roberts-Grey is a seasoned health and finance journalist